Vir Biotechnology Inc (VIR) — Capital Reinvestment Ratio
Vir Biotechnology Inc (VIR) has a Capital Reinvestment Ratio of 0.36x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.13 Million) in capital expenditures ($12.60 Million). See VIR net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vir Biotechnology Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Vir Biotechnology Inc's Capital Reinvestment Ratio across 1 annual periods. Check VIR total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Vir Biotechnology Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Vir Biotechnology Inc from 2022 to 2022. For live market cap and broader valuation context, see VIR market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $1.66 Billion | $68.01 Million | — |